Protective effects of prostaglandin E1 on hepatocytes

World Journal of Gastroenterology

Volumn 6, Issue 3, 2000, Pages 326-329

  Liu, Xian Ling ^a   Fan, Dai Ming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E1;

ARTHRITIS; CELL PROTECTION; CLINICAL TRIAL; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; ERYTHROCYTE APLASIA; EXPERIMENTAL MODEL; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPEROSTOSIS; LIVER BIOPSY; LIVER CELL; LIVER FAILURE; LIVER FUNCTION; NONHUMAN; REVIEW; TREATMENT OUTCOME; VIRUS HEPATITIS; VIRUS INFECTION;

EID: 0034083251     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v6.i3.326     Document Type: Review

References (15)

1. Beck PL, McKnight GW, Kelly JK, Wallace JL, Lee SS. Hepatic and gastric cytoprotective effects of long-term prostaglandin E1 administration in cirrhotic rats. Gastroenterology, 1993;105:1483-1489
2. Gu CH, Cao R, Wang GX, Li MT, Liu SY. Protective effect of prostaglandin E on hepatocytes and its value of early treatment of severe viral hepatitis. Zhonghua Neike Zazhi, 1991;30:17-20
3. Suzuki A, Hagino M, Yasuda N, Sagawa K, Terawaki T, Ogawa M, Kondo K, Hamanaka N, Tanaka M, Aze Y. Inhibitory effects of prostaglandin E1. alpha-cyclodextrin ( PGE1. CD ) on dimethylnitrosamine - induced acute liver damage in rats. Nippon Yakurigaku Zasshi, 1995;105:221-229
4. Sinclair SB, Greig PD, Blendis LM, Abecassis M, Roberts EA, Phillips MJ, Cameron R, Levy GA . Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report. J Clin Invest, 1989;84:1063-1069
5. Flowers M, Sherker A, Sinclair SB, Greig PD, Cameron R, Phillips MJ, Blendis L, Chung SW, Levy GA. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation. Transplantation, 1994;58:183-192
6. Bojic I, Begovic V, Mijuskovic P. Treatment of patients with subfulminant forms of viral hepatitis B using prostaglandin E1. Vojnosanit Pregl, 1995;52:471-475
7. Tomida S, Matsuzaki Y, Nishi M, Ikegami T, Chiba T, Abei M, Tanaka N, Osuga T, Sato Y, Abe T, Severe acute hepatitis A associated with acute pure red cell aplasia. J Gastroenterol, 1996;31: 612-617
8. Reus S, Priego M, Boix V, Torrus D, Portilla J. Can alprostadil improve liver failure in HIV-infected patients with severe acute viral hepatitis? J Infect, 1998;37:84-86
9. Tsukada K, Sakaguchi T, Aono T, Ishizuka D, Fujita N, Hatakeyama K, Indocyanine green disappearance enhanced by prostaglandin E1 in patients with hepatic resection. J Surg Res, 1996;66:64-68
10. Qgawa M, Mori T, Mori Y, Ueda S, Yoshida H, Kato I, Iesato K, Wakashin Y, Wakashin M, Okuda K. Inhibitory effects of prostaglandin E1 on T - cell mediated cytotoxicity against isolated mouse liver cells. Gastroenterology, 1988;94:1024-1030
11. Shimura T, Miyazaki M, Koshikawa H, Takahashi O, Sugasawa H, Fujimoto S, Okui K. Cyclic AMP- and ATP-mediated stimulation of DNA synthesis following partial hepatectomy by prostaglandin-E1 in D-galactosamine injured liver. Nippon Geka Gakkai Zasshi, 1985;86: 1618-1624
12. Kurokawa T, Nonami T, Harada A, Nakao A, Sugiyama S, Ozawa T, Takagi H. Effects of prostaglandin E1 on the recovery of ischemia-induced liver mitochondrial dysfunction in rats with cirrhosis. Scand J Gastroenterol, 1991;26:269-274
13. Masaki N, Ohta Y, Shirataki H, Ogata I, Hayashi S, Yamada S, Hirata K, Nagoshi S, Mochida S, Tomiya T, Ohno A, Ohta Y, Fujiwara K. Hepatocyte membrane stabilization by prostaglandins E1 and E2: favorable effects on rat liver injury. Gastroenterology, 1992; 102:572-576
14. Cattral MS, Altraif I, Greig PD, Blendis L, Levy GA. Toxic effects of intravenous and oral prostaglandin E therapy in patients with liver disease. Am J Med, 1994;97:369-373
15. Mizushima Y, Hoshi K . Review: recent advances in lipid microsphere technology for targeting prostaglandin delivery. J Drug Target, 1993; 1:93-100